{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:03:49Z","timestamp":1782860629850,"version":"3.54.5"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"vor","delay-in-days":319,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Reactivation of chronic hepatitis C virus (HCV) infection has been reported in cancer patients receiving chemotherapy. In this study, we report the first case, to our knowledge, of thalidomide-induced acute exacerbation and reactivation of chronic HCV infection complicating management of multiple myeloma. Sofosbuvir-based antiviral therapy helped achieve viral clearance and normalization of liver enzymes, thus allowing access to future potentially life-saving chemotherapy agents.<\/jats:p>","DOI":"10.1093\/ofid\/ofv211","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T01:25:11Z","timestamp":1452561911000},"source":"Crossref","is-referenced-by-count":10,"title":["Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy"],"prefix":"10.1093","volume":"3","author":[{"given":"Parag","family":"Mahale","sequence":"first","affiliation":[{"name":"Departments of Infectious Diseases, Infection Control, and Employee Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba K.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Lymphoma\/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kyvernitakis","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases, Infection Control, and Employee Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrys A.","family":"Torres","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases, Infection Control, and Employee Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"2020081005372507400_OFV211C1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2012.07.031","article-title":"Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients","volume":"57","author":"Mahale","year":"2012","journal-title":"J Hepatol"},{"key":"2020081005372507400_OFV211C2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3816\/CLM.2007.n.039","article-title":"Liver involvement in multiple myeloma","volume":"7","author":"Bhandari","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"2020081005372507400_OFV211C3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","author":"AASLD\/IDSA HCV Guidance Panel","year":"2015","journal-title":"Hepatology"},{"key":"2020081005372507400_OFV211C4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","article-title":"Thalidomide: a review of approved and investigational uses","volume":"25","author":"Matthews","year":"2003","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"2020081005372507400_OFV211C5","doi-asserted-by":"crossref","first-page":"I107","DOI":"10.1136\/ard.58.2008.i107","article-title":"Immunomodulation by thalidomide and thalidomide analogues","volume":"58","author":"Corral","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"2020081005372507400_OFV211C6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.2008.01653.x","article-title":"Hepatitis B reactivation after thalidomide","volume":"38","author":"Grigg","year":"2008","journal-title":"Intern Med J"},{"key":"2020081005372507400_OFV211C7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajh.1062","article-title":"Thalidomide-associated hepatitis: a case report","volume":"66","author":"Fowler","year":"2001","journal-title":"Am J Hematol"},{"key":"2020081005372507400_OFV211C8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrclinonc.2012.1","article-title":"Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer","volume":"9","author":"Torres","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"2020081005372507400_OFV211C9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1196\/annals.1423.046","article-title":"Impact of steroids on hepatitis C virus replication in vivo and in vitro","volume":"1110","author":"Henry","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"2020081005372507400_OFV211C10","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1111\/j.1365-2893.2011.01505.x","article-title":"Inhibition of IkappaB kinase by thalidomide increases hepatitis C virus RNA replication","volume":"19","author":"Rance","year":"2012","journal-title":"J Viral Hepat"},{"key":"2020081005372507400_OFV211C11","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.bbmt.2015.07.033","article-title":"Hepatitis C virus infection among hematopoietic cell transplant donors and recipients: American Society for Blood and Marrow Transplantation Task Force recommendations","volume":"21","author":"Torres","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081005372507400_OFV211C12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.12.010","article-title":"Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents","author":"Kyvernitakis","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081005372507400_OFV211C13","first-page":"114A","article-title":"Concomitant use of chemotherapy and antivirals in hepatitis C virus infected cancer patients","volume":"62","author":"Mahale","year":"2015","journal-title":"Hepatology"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/3\/1\/ofv211\/33600827\/ofv211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/3\/1\/ofv211\/33600827\/ofv211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:39:30Z","timestamp":1597052370000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofv211\/2460687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofv211","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016]]},"published":{"date-parts":[[2015,12,28]]},"article-number":"ofv211"}}